Frost & Sullivan awards WuXi AppTec with 2026 Global Company of the Year Recognition for CRDMO Leadership
Integrated capabilities, global capacity, and customer-centric innovation strengthen WuXi AppTec's position in the evolving contract research, development, and manufacturing (CRDMO) landscape. SAN ANTONIO, Oct. 20, 2026 /PRNewswire/ -- Frost &...
Ajinomoto Bio-Pharma Services Unveils Refreshed Global Brand, Showcasing its Strength in Specialization
Reflects the depth of expertise and innovation Aji Bio-Pharma brings to customers navigating increasingly demanding development and manufacturing challenges TOKYO, Oct. 5, 2026 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a...
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
Acquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs CordenPharma has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide CDMO with facilities in North...
XtalPi Holdings Announces Full Year 2025 Annual Results
HONG KONG, March 25, 2026 /PRNewswire/ -- Financial Highlights: Revenues for year 2025 were RMB802.6 million, representing a year-over-year increase of 201.2%. Net profit for year 2025 reached reached RMB 134.6 million, while adjusted net profit...
Telangana (India) Sets Global Ambition with Next-Gen Life Sciences Policy 2026-30
Positioning Telangana among the world's top five life sciences clusters by 2030 Targets USD 25 billion in investments Shifts focus from scale-led manufacturing to innovation-driven, value creation DAVOS, Switzerland, Jan. 22, 2026 /PRNewswire/ --...